Jul 20, 2020 / 11:00AM GMT
Operator
Hello, and welcome to the ReNeuron Preliminary Results Conference Call. (Operator Instructions) And just to remind you, this conference call is being recorded. Today, I'm pleased to present Olav Hellebø, CEO. Please go ahead with your meeting.
Olav Hellebø,ReNeuron Group plc-CEO&Director
Thank you very much. Good morning. Thanks, everyone, for joining this analyst meeting. I hope everyone is well, and we look forward to having one of these face-to-face again before too long.
Before we start digging into the presentation, if you do not have a copy of the slides, please go on to our website. There should be a link at the front page there or in the investor section where you can find the slides that will be easy to follow.
So let's start by turning to Slide #2 which is the disclaimer, so please note that. Then we'll jump to Slide #3. As you know already, ReNeuron is a leading cell therapy company. We're present in the U.K. and the U.S. And we have allogeneic retinal and neural stem cell technology
Full Year 2020 ReNeuron Group PLC Earnings Call Transcript
Jul 20, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers